Rebecca Berhanu to Cost-Benefit Analysis
This is a "connection" page, showing publications Rebecca Berhanu has written about Cost-Benefit Analysis.
Connection Strength
0,071
-
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis. Int J Tuberc Lung Dis. 2020 04 01; 24(4):376-382.
Score: 0,038
-
Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa. Int J Tuberc Lung Dis. 2018 04 01; 22(4):393-398.
Score: 0,033